Company Filing History:
Years Active: 2021
Title: Francesco Colotta: Innovator in Renal Function Prognostics
Introduction
Francesco Colotta is a notable inventor based in Segrate, Italy. He has made significant contributions to the field of medical diagnostics, particularly in the area of renal function. His innovative approach has the potential to improve patient outcomes for those at risk of renal injury.
Latest Patents
Colotta holds a patent for the invention titled "Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker." This invention relates to a method for predicting or stratifying the risk of worsening renal function (WRF) in patients. By measuring levels of 1,25-dihydroxyvitamin D (1,25(OH)D) in a biological sample and correlating them with parathyroid hormone (PTH) levels, the invention provides a ratio that indicates the risk of worsening renal function.
Career Highlights
Francesco Colotta is associated with Diasorin S.p.a., a company known for its advancements in diagnostic solutions. His work at Diasorin has allowed him to focus on innovative methods that enhance the understanding of renal health.
Collaborations
Colotta has collaborated with notable colleagues such as Fabrizio Bonelli and Frank Blocki. These partnerships have contributed to the development and refinement of his innovative approaches in medical diagnostics.
Conclusion
Francesco Colotta's work exemplifies the intersection of innovation and healthcare, particularly in the realm of renal function assessment. His contributions are poised to make a significant impact on patient care and medical diagnostics.